Bioventus, Inc. (BVS)
12.85
+0.16
(+1.26%)
USD |
NASDAQ |
Oct 09, 10:18
Bioventus Price to Book Value : 3.839 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 3.791 |
| October 07, 2026 | 3.815 |
| October 06, 2026 | 3.914 |
| October 05, 2026 | 4.039 |
| October 02, 2026 | 3.923 |
| October 01, 2026 | 4.018 |
| September 30, 2026 | 4.072 |
| September 29, 2026 | 4.183 |
| September 28, 2026 | 4.189 |
| September 25, 2026 | 4.126 |
| September 24, 2026 | 4.039 |
| September 23, 2026 | 4.066 |
| September 22, 2026 | 4.078 |
| September 21, 2026 | 3.977 |
| September 18, 2026 | 3.857 |
| September 17, 2026 | 3.774 |
| September 16, 2026 | 3.944 |
| September 15, 2026 | 3.884 |
| September 14, 2026 | 3.932 |
| September 11, 2026 | 3.878 |
| September 10, 2026 | 3.902 |
| September 09, 2026 | 4.072 |
| September 08, 2026 | 4.132 |
| September 04, 2026 | 4.204 |
| September 03, 2026 | 4.290 |
| Date | Value |
|---|---|
| September 02, 2026 | 4.293 |
| September 01, 2026 | 4.084 |
| August 31, 2026 | 4.078 |
| August 28, 2026 | 4.135 |
| August 27, 2026 | 4.120 |
| August 26, 2026 | 4.174 |
| August 25, 2026 | 4.207 |
| August 24, 2026 | 4.189 |
| August 21, 2026 | 4.296 |
| August 20, 2026 | 4.281 |
| August 19, 2026 | 4.386 |
| August 18, 2026 | 4.272 |
| August 17, 2026 | 4.147 |
| August 14, 2026 | 4.260 |
| August 13, 2026 | 4.15 |
| August 12, 2026 | 4.157 |
| August 11, 2026 | 4.138 |
| August 10, 2026 | 4.171 |
| August 07, 2026 | 4.220 |
| August 06, 2026 | 4.177 |
| August 05, 2026 | 4.559 |
| August 04, 2026 | 4.010 |
| August 03, 2026 | 4.024 |
| July 31, 2026 | 3.935 |
| July 30, 2026 | 3.938 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Accuray, Inc. | 0.6530 |
| Micron Solutions, Inc. | -- |
| IDEXX Laboratories, Inc. | 25.49 |
| Neogen Corp. | 1.248 |
| Orthofix Medical, Inc. | 0.8712 |
Price to Book Value Related Metrics
| PE Ratio | 16.57 |
| PS Ratio | 1.540 |
| Price to Free Cash Flow | 9.575 |
| Price | 12.85 |
| Earnings Yield | 6.03% |
| Market Cap | 876.52M |
| Operating PE Ratio | 14.58 |
| Normalized PE Ratio | 15.87 |